1. Home
  2. Labeler Index
  3. Redpharm Drug, Inc.
  4. 67296-1818
  5. NDC Package Code: 67296-1818-3 Tivicay

NDC Package 67296-1818-3 Tivicay

View Billable Units, 11-Digit Format, RxNorm

Table of Contents

    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
67296-1818-3
Package Description:
3 TABLET, FILM COATED in 1 BOTTLE
Product Code:
67296-1818
Proprietary Name:
Tivicay
Usage Information:
Dolutegravir is used with other HIV medications to help control HIV infection. It helps to decrease the amount of HIV in your body so your immune system can work better. This lowers your chance of getting HIV complications (such as new infections, cancer) and improves your quality of life. Dolutegravir belongs to a class of drugs known as integrase inhibitors. It blocks the virus from growing and infecting more cells. Dolutegravir is not a cure for HIV infection. To decrease your risk of spreading HIV disease to others, do all of the following: (1) continue to take all HIV medications exactly as prescribed by your doctor, (2) always use an effective barrier method (latex or polyurethane condoms/dental dams) during all sexual activity, and (3) do not share personal items (such as needles/syringes, toothbrushes, and razors) that may have contacted blood or other body fluids. Consult your doctor or pharmacist for more details.
11-Digit NDC Billing Format:
67296181803
NDC to RxNorm Crosswalk:
  • RxCUI: 1433873 - dolutegravir 50 MG Oral Tablet
  • RxCUI: 1433873 - dolutegravir 50 MG (as dolutegravir sodium 52.6 MG) Oral Tablet
  • RxCUI: 1433879 - Tivicay 50 MG Oral Tablet
  • RxCUI: 1433879 - dolutegravir 50 MG Oral Tablet [Tivicay]
  • RxCUI: 1433879 - Tivicay 50 MG (as dolutegravir sodium) Oral Tablet
    • Labeler Name:
    Redpharm Drug, Inc.
    Sample Package:
    No
    Start Marketing Date:
    08-13-2013
    Listing Expiration Date:
    12-31-2021
    Exclude Flag:
    I
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 67296-1818-3?

    The NDC Packaged Code 67296-1818-3 is assigned to a package of 3 tablet, film coated in 1 bottle of Tivicay, labeled by Redpharm Drug, Inc.. The product's dosage form is and is administered via form.

    Is NDC 67296-1818 included in the NDC Directory?

    No, Tivicay with product code 67296-1818 is excluded from the NDC Directory because it's listing has been INACTIVATED by FDA. The product was first marketed by Redpharm Drug, Inc. on August 13, 2013 and its listing in the NDC Directory is set to expire on December 31, 2021 if the product is not updated or renewed by the manufacturer.

    What is the 11-digit format for NDC 67296-1818-3?

    The 11-digit format is 67296181803. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 5-4-1 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    5-4-167296-1818-35-4-267296-1818-03